Kos diabetes group: the ozempica rip-off
Reducing the cost of insulin in the US has been a great achievement, but we must, in Bidens parlance, finish the job. Ozempic and other brands of semaglutide cost five times as much in the United States as in other countries, or even more. Novo Nordisk researchers are serious about finding ways to help diabetics, … Read more